BioAmber (BIOA) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts BIOA Hot Sheet
Join SI Premium – FREE
BioAmber (NYSE: BIOA) reported Q4 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.11 million versus the consensus estimate of $830 thousand.
For earnings history and earnings-related data on BioAmber (BIOA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioAmber (BIOA) Reports Q2 Loss of $0.58
- Cadre Holdings (CDRE) Misses Q2 EPS by 5c; Offers Guidance
- Kronos Worldwide (KRO) Tops Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
